Bristol-Myers Squibb Company (NYSE:
BMY) will host a conference call at 8:30 a.m. (ET) on Wednesday,
September 3 to review data presented at the European Society of
Cardiology (ESC) meeting, being held from August 30 to September 3 in
Munich. Company executives will provide an overview of data presented at
the meeting on the cardiovascular portfolio and address inquiries from
investors and analysts.
Investors and the general public are invited to listen to a live webcast
of the call at http://www.bms.com/ir
or by dialing 913-312-0727, confirmation code: 4875228. A replay of the
call will be available beginning at 12:00 p.m. (ET) on September 3
through midnight (ET) on September 17. The replay can be accessed at http://www.bms.com/ir
or by dialing 402-280-9013, confirmation code: 4875228.
Bristol-Myers Squibb is a global pharmaceutical company whose mission is
to extend and enhance human life.
Bristol-Myers Squibb Company
Media:
Ken Dominski,
609-252-5251
ken.dominski@bms.com
or
Investors:
John
Elicker, 212-546-3775
john.elicker@bms.com
